Publications
5808 Results
- Journal / Conference
- European Urology, 63(4):717-723
- Year
- 2013
- Research Committee(s)
- Genitourinary
- PMID
- PMID23206856
- PMC
- PMC4127896
- Study Number(s)
- S0031, S0306
Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: a retrospective analysis of pooled, prospective Phase 2 trials
- Journal / Conference
- Annals of Thoracic Surgery 95(2):750-756
- Year
- 2013
- Research Committee(s)
- Lung
- PMID
- PMID23336898
- PMC
- Reviews not within the scope of the Public Access Policy
Cooperative group clinical trials in general thoracic surgery: report from the 2012 Robert Ginsberg Clinical Trials Meeting of the General Thoracic Surgical Club
- Journal / Conference
- Society for Clinical Trials Annual Meeting (May 19-22, 2013, Boston, MA), poster presentation
- Year
- 2013
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000
Factors associated with retention of African-American and white participants in a prostate cancer prevention trial
- Journal / Conference
- Journal of Clinical Oncology 31(suppl; abstr 8515); ASCO annual meeting 2013, oral presentation
- Year
- 2013
- Research Committee(s)
- Myeloma
- Study Number(s)
- S0120
Clinical, genomic, and imaging predictors of malignancy: analysis ofthe first U.S. cooperative group prospective clinical trial in symptomatic monoclonal gammopathies (SWOG S0120)
- Journal / Conference
- Blood 122(20):3432-3439;
- Year
- 2013
- Research Committee(s)
- Leukemia
- PMID
- PMID24092933
- PMC
- PMC3829116
- Study Number(s)
- S0703
A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemia
- Journal / Conference
- American Journal of Epidemiology 178(5):741-751;
- Year
- 2013
- Research Committee(s)
- Cancer Control
- PMID
- PMID23813705
- PMC
- PMC3755644
- Study Number(s)
- SWOG-9217
Should modest elevations in prostate specific antigen or international prostate symptom score, or their rates of increase over time, be used as surrogate measures of incident benign prostatic hyperplasia?
- Journal / Conference
- San Antonio Breast Cancer Symposium, abstr. OT3-3-02; poster presentation;
- Year
- 2013
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0812
Phase IIB randomized double-blind placebo-controlled biomarker modulation study of high dose vitamin D in premenopausal women at high-risk for breast cancer: SWOG S0812
- Journal / Conference
- San Antonio Breast Cancer Symposium, abst. S5-07; oral presentation;
- Year
- 2013
- Research Committee(s)
- Breast
- Study Number(s)
- S0500
SWOG S0500 - a randomized phase III trial to test the strategy of changing therapy versus maintaining therapy for metastatic breast cancer patients who have elevated circulating tumor cell (CTC) levels at first follow-up assessment
- Journal / Conference
- San Antonio Breast Cancer Symposium, abst S1-07; oral presentation;
- Year
- 2013
- Research Committee(s)
- Breast
- Study Number(s)
- E1199, E2197
Prognostic value of tumor-infiltrating lympocytes (TILs) in two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199
- Journal / Conference
- Haematologica 98(supplement 2):P010;CS, p.4; International Symposium on Hodgkin Lymphoma (Oct.12-15, 2013, Cologne, Germany), poster presenttion;
- Year
- 2013
- Research Committee(s)
- Lymphoma
- Study Number(s)
- E2496